-transparent.png){kind=logo}
We have studied four girls with central precocious puberty treated with cyproterone acetate for a mean of 3.6 years (range 1.5-6.3 years). Pelvic ultrasound assessment demonstrated suppression of the ovarian morphology of central precocious puberty despite the presence of spontaneous pulsatile gonadotrophin secretion at night. We suggest that the previously reported effects on gonadotrophin secretion induced by cyproterone acetate therapy, administered in recommended doses, are minor and that the predominant effect of cyproterone acetate in the treatment of girls with central precocious puberty is direct inhibition of ovarian steroidogenesis.
Related Publications
R Stanhope, and
P J Pringle, and
J Adams, and
S L Jeffcoate, and
C G Brook
March 1991,
Ceskoslovenska pediatrie,
R Stanhope, and
P J Pringle, and
J Adams, and
S L Jeffcoate, and
C G Brook
January 1992,
Hormone research,
R Stanhope, and
P J Pringle, and
J Adams, and
S L Jeffcoate, and
C G Brook
May 1999,
European journal of pediatrics,
R Stanhope, and
P J Pringle, and
J Adams, and
S L Jeffcoate, and
C G Brook
July 1977,
The Journal of clinical endocrinology and metabolism,
R Stanhope, and
P J Pringle, and
J Adams, and
S L Jeffcoate, and
C G Brook
July 1975,
Endokrinologie,
R Stanhope, and
P J Pringle, and
J Adams, and
S L Jeffcoate, and
C G Brook
January 1981,
Journal of endocrinological investigation,
R Stanhope, and
P J Pringle, and
J Adams, and
S L Jeffcoate, and
C G Brook
January 1981,
Acta medica portuguesa,
R Stanhope, and
P J Pringle, and
J Adams, and
S L Jeffcoate, and
C G Brook
April 1974,
Pediatric research,
R Stanhope, and
P J Pringle, and
J Adams, and
S L Jeffcoate, and
C G Brook
March 1976,
Archives of disease in childhood,
R Stanhope, and
P J Pringle, and
J Adams, and
S L Jeffcoate, and
C G Brook
October 1973,
Acta endocrinologica,
